These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2429788)

  • 21. Plasma proteinase inhibitors.
    Bodmer JL; Schnebli HP
    Schweiz Med Wochenschr; 1984 Oct; 114(40):1359-63. PubMed ID: 6208604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of heparin-catalyzed human antithrombin III activity by nonenzymatic glycosylation. Possible role in fibrin deposition in diabetes.
    Brownlee M; Vlassara H; Cerami A
    Diabetes; 1984 Jun; 33(6):532-5. PubMed ID: 6724150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
    Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW
    Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteases and antiproteases related to the coagulation system in plasma and ascites--an approach to differentiate between malignant and cirrhotic ascites.
    Schölmerich J; Zimmermann U; Köttgen E; Volk BA; Ehlers S; Gerok W
    Klin Wochenschr; 1987 Jul; 65(14):634-8. PubMed ID: 2442449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum protease inhibitor concentrations and total antitrypsin activity in diabetic and non-diabetic children during adolescence.
    Lisowska-Myjak B; Pachecka J; Kaczyńska B; Miszkurka G; Kadziela K
    Acta Diabetol; 2006 Dec; 43(4):88-92. PubMed ID: 17211556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma protease inhibitors in premature infants: influence of gestational age, postnatal age, and health status.
    Andrew M; Massicotte-Nolan PM; Karpatkin M
    Proc Soc Exp Biol Med; 1983 Sep; 173(4):495-500. PubMed ID: 6193532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Plasma proteinase inhibitors and their clinical significance].
    Prandota J; Kotecki L
    Pediatr Pol; 1995 Aug; 70(8):667-72. PubMed ID: 8668369
    [No Abstract]   [Full Text] [Related]  

  • 28. Proteases and protease inhibitors in taurocholate-induced acute pancreatitis in rats.
    Kruse P; Hage E; Lasson A
    Int J Pancreatol; 1999 Apr; 25(2):113-21. PubMed ID: 10360224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum antithrombin III and alpha-2-antiplasmin concentration in patients with lung carcinoma.
    Dabrowska M; Prokopowicz J; Kemona H; Kretowska J; Kulik S; Głuszczak M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(5):641-6. PubMed ID: 2465244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of platelet activation, plasma antithrombin III and alpha2-antiplasmin activities in hypertensive patients.
    Tomczykowska M; Bielak J; Bodys A
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):15-20. PubMed ID: 15314952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo catabolism of alpha 1-antichymotrypsin is mediated by the Serpin receptor which binds alpha 1-proteinase inhibitor, antithrombin III and heparin cofactor II.
    Pizzo SV; Mast AE; Feldman SR; Salvesen G
    Biochim Biophys Acta; 1988 Nov; 967(2):158-62. PubMed ID: 3263884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteases and protease inhibitors in cerulein-induced acute pancreatitis in rats.
    Kruse P; Lasson A; Hage E
    J Surg Res; 1999 Aug; 85(2):294-300. PubMed ID: 10423332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antithrombin III and alpha 2-antiplasmin in blood of patients operated on for benign prostatic hyperplasia].
    Zietek Z; Iwan-Zietek I; Kotschy M; Tyloch F
    Pol Tyg Lek; 1996 Feb; 51(6-9):75-6. PubMed ID: 8756735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
    Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
    J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alteration of plasma proteinase-antiproteinase system in type 1 diabetic patients. Influence of sex and relationship with metabolic control.
    Finotti P; Piccoli A; Carraro P
    Diabetes Res Clin Pract; 1992 Oct; 18(1):35-42. PubMed ID: 1280191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunological determination of proteinase inhibitor complexes (PICs) and their behaviour during plasma derivate treatment in septic infections.
    Egbring R; Seitz R; Blanke H; Menges T; Südhoff R; Stober T; Kolb G; Lerch L
    Prog Clin Biol Res; 1989; 308():971-6. PubMed ID: 2789404
    [No Abstract]   [Full Text] [Related]  

  • 37. The functional role of acute phase plasma proteinase inhibitors.
    Travis J; Shieh BH; Potempa J
    Tokai J Exp Clin Med; 1988 Dec; 13(6):313-20. PubMed ID: 3152555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unglycosylated rat alpha 1-proteinase inhibitor has a six-fold shorter plasma half-life than the mature glycoprotein.
    Weber W; Steube K; Gross V; Tran-Thi TA; Decker K; Gerok W; Heinrich PC
    Biochem Biophys Res Commun; 1985 Jan; 126(1):630-5. PubMed ID: 3871610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocyte uptake of alpha 1-proteinase inhibitor-trypsin complexes in vitro: evidence for a shared uptake mechanism for proteinase complexes of alpha 1-proteinase inhibitor and antithrombin III.
    Fuchs HE; Michalopoulos GK; Pizzo SV
    J Cell Biochem; 1984; 25(4):231-43. PubMed ID: 6334690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The determination of antithrombin III, alpha 2-macroglobulin and alpha 2-antiplasmin in plasma by laser nephelometry.
    Schmitz-Huebner U; Nachbar J; Asbeck F
    J Clin Chem Clin Biochem; 1980 Apr; 18(4):221-5. PubMed ID: 6155426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.